John Densmore
About
In The Last Decade
John Densmore
26 papers receiving 688 citations
Peers
Comparison fields: 5 of 68
- Immunology 337
- Radiology, Nuclear Medicine and Imaging 267
- Pathology and Forensic Medicine 257
- Oncology 219
- Genetics 202
Countries citing papers authored by John Densmore
This map shows the geographic impact of John Densmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Densmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Densmore more than expected).
Fields of papers citing papers by John Densmore
This network shows the impact of papers produced by John Densmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Densmore. The network helps show where John Densmore may publish in the future.
Co-authorship network of co-authors of John Densmore
This figure shows the co-authorship network connecting the top 25 collaborators of John Densmore. A scholar is included among the top collaborators of John Densmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Densmore. John Densmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 24 | |
| 4 | Inherited and acquired hematologic disorders in athletes. | 1 |
| 5 | 4 | |
| 6 | 14 | |
| 7 | Hodgkin's in the Elderly: More Questions Than Answers | 1 |
| 8 | 124 | |
| 9 | 35 | |
| 10 | 40 | |
| 11 | 5 | |
| 12 | 7 | |
| 13 | 276 | |
| 14 | Pegfilgrastim use during chemotherapy: current and future applications. | 8 |
| 15 | 6 | |
| 16 | 8 | |
| 17 | 7 | |
| 18 | 23 | |
| 19 | 4 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.